Objective: To examine the psychometric properties of the 30-item teacher’s version of the Child and Adolescent Symptom Inventory Progress Monitor (CASI-PM-T), a DSM-IV-referenced rating scale for monitoring change in ADHD and co-occurring symptoms in youths receiving behavioral or pharmacological interventions. Method: Three separate studies were conducted to determine (a) which items from longer diagnostic instruments were most representative of ADHD and commonly occurring psychiatric syndromes in clinic-referred samples ( N = 406) aged between 3 and 18 years, (b) the reliability and validity of the CASI-PM-T in students enrolled in full-time special education programs at the elementary and middle school levels (N = 169), and (c) the clinical utility of measuring behavioral change in a sample of outpatient ADHD children beginning treatment with stimulant medication. Results: Internal consistency reliabilities (.71-.94), 2-week test-retest reliabilities (r = .70-.90), and interrater agreement (r = .44-.78) for the CASI-PM-T symptom categories were comparable to the full-length CASI-4. Convergence was also found between corresponding CASI-PM-T categories and consultant diagnoses of ADHD and ODD as well as school functioning measures of grade-point average and suspensions. The CASI-PM-T also demonstrated sensitivity to stimulant medication treatment effects. Conclusion: Findings provide preliminary support for the reliability, validity, and clinical utility of the CASI-PM-T. (J. of Att. Dis. 2011; 15(3) 235-245)
Abikoff, H.B., Vitiello, B., Riddle, M.A., Cunningham, C., Greenhill, L.L., Swanson, J.M., et al. (2008). Methylphenidate effects on functional outcomes in the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). Journal of Child and Adolescent Psychopharmacology , 17, 581-592.
2.
Achenbach, T.M. ( 1991). Manual for the Teacher’s Report Form and 1991 profile . Burlington: University of Vermont Department of Psychiatry.
3.
Achenbach, T.M., McConaughy, S.H., & Howell, C.T. ( 1987). Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychological Bulletin, 101, 213-232.
Fisher, P.A., Gunnar, M.R., Chamberlain, P., & Reid, J.B. ( 2000). Preventive intervention for maltreated preschool children: Impact on children’s behavior, neuroendocrine activity, and foster parent functioning. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1356-1364.
7.
Gadow, K.D., Drabick, D.A.G., Loney, J., Sprafkin, J., Salisbury, H., Azizian, A., et al. (2004). Comparison of ADHD symptom subtypes as source-specific syndromes. Journal of Child Psychology and Psychiatry, 45, 1135-1149.
8.
Gadow, K.D., Nolan, E.E., Sverd, J., Sprafkin, J., & Schneider, J. ( 2008). Methylphenidate in children with oppositional defiant disorder and both co-morbid chronic multiple tic disorder and ADHD. Journal of Child Neurology, 23, 981-990.
9.
Gadow, K.D., & Sprafkin, J. ( 1986). Stony Brook Child Psychiatric Checklist-3. Stony Brook: State University of New York.
Gadow, K.D., & Sprafkin, J. ( 2000). Early Childhood Inventory-4 Screening Manual. Stony Brook, NY: Checkmate Plus.
14.
Gadow, K.D., & Sprafkin, J. ( 2002). Child Symptom Inventory-4 Screening and Norms Manual . Stony Brook, NY: Checkmate Plus .
15.
Gadow, K.D., & Sprafkin, J. ( 2008). Adolescent Symptom Inventory-4 Screening and Norms Manual . Stony Brook, NY: Checkmate Plus .
16.
Gadow, K.D., & Sprafkin, J. ( 2009). The Symptom Inventories: An Annotated Bibliography [On-line] . Stony Brook, NY: Checkmate Plus . Available from http://www.checkmateplus.com
17.
Gadow, K.D., Sprafkin, J., & Nolan, E.E. ( 2001). DSM-IV symptoms in community and clinic preschool children . Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1383-1392.
18.
Gadow, K.D., Sprafkin, J., Salisbury, H., Schneider, J., & Loney, J. ( 2004). Further validity evidence for the teacher version of the Child Symptom Inventory-4. School Psychology Quarterly , 19, 50-71.
19.
Goodman, R. ( 1997). The Strengths and Difficulties Questionnaire: A research note. Journal of Child Psychology and Psychiatry, 38, 581-586.
20.
Keller, M.C., & Miller, G. ( 2006). Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best?Behavior and Brain Sciences, 29, 385-452.
21.
Kendler, K.S. ( 2006). Reflections of the relationship between psychiatric genetics and psychiatric nosology. American Journal of Psychiatry, 163, 1138-1146.
22.
Kronenberg, S., Frisch, A., Rotberg, B., Carmel, M., Apter, A., & Weizman, A. ( 2008). Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. Pharmacogenomics, 9, 1725-1736.
23.
Lavigne, J.V., Cromley, T., Sprafkin, J., & Gadow, K.D. (in press). The Child and Adolescent Symptom Inventory-Progress Monitor: A brief DSM-IV-referenced parent-report scale for children and adolescents . Journal of Child and Adolescent Psychopharmacology.
24.
Loney, J., & Milich, R. ( 1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich & D.L. Routh (Eds.), Advances in developmental and behavioral pediatrics (Vol. 3, pp. 113-147), Greenwich, CT: JAI Press.
25.
Luby, J.L., Heffelfinger, A.K., Mrakotsky, C., Brown, K.M., Hessler, M.J., Wallis, J.M., et al. (2003). The clinical picture of depression in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 340-348.
26.
Mattison, R.E. ( 2004). Universal measures of school functioning in middle school special education students. Behavioral Disorders, 29, 359-371.
27.
Mattison, R.E., Gadow, K.D., Sprafkin, J., Nolan, E.E., & Schneider, J. ( 2003). A DSM-IV-referenced teacher rating scale for use in clinical management. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 442-449.
MTA Cooperative Group. (1999). 14 month randomized clinical trial of treatment strategies for children with attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
30.
Murphy, D.L., Fox, M.A., Timpano, K.R., Moya, P.R., Ren-Patterson, R., Andrews, A.M., et al. (2008). How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems . Neuropharmacology, 55, 932-960.
31.
Naglieri, J.A., LeBuffe, P.A., & Pfeiffer, S.I. (1994). Devereux Scales of Mental Disorders. San Antonio, TX: Psychological Corporation.
32.
Pfiffner, L.J., Mikami, A.Y., Huang-Pollock, C., Easterlin, B., Zalecki, C., & McBurnett, K., (2007). A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1041-1050.
33.
Reynolds, C.R., & Kamphaus, R.W. (1992). Behavior assessment system for children. Circle Pines, MN: American Guidance Service.
34.
Serretti, A., Calati, R., Mandelli, L., & De Ronchi, D. ( 2006). Serotonin gene variants and behavior: A comprehensive review. Current Drug Targets, 7, 1659-1669.
Sprafkin, J., & Gadow, K.D. ( 1996b). Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 6, 215-228.
